WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced that Frank McGillin, Senior Vice President and General Manager, Consumer will participate in a panel discussion entitled "The Rise of Enterprise & Condition-Specific Wearables” during the Fifth Annual Digital Health Summer Summit. Digital Health is co-located with the 2016 Bio International Convention at the Moscone Center in San Francisco and the panel discussion will be held on Tuesday, June 7 at 11:15am (Pacific).
Mr. McGillin will join other industry leaders including moderator Chris Bergstrom, Associate Director - Digital Health, BCG; Rich Buchler Co-Founder and CEO, VIZR Tech; Ben Hwang, CEO, Profusa; and Ashwin Pushpala, CEO, Sano Intelligence Inc.
"The theme of the Digital Health Summit event is Igniting the Tipping Point," said Mr. McGillin, "The fact that digital health is also a track at BIO 2016 is a good indication that the time is right for innovative technology that addresses the burden of chronic disease. Products like Quell® are an example of what is possible in a sophisticated connected consumer health device."
The Fifth Annual Digital Health Summer Summit at BIO 2016 takes a deep dive into the elements of a successful digital health venture and showcases the latest digital health innovations from the industry’s leaders and organizations who will explore the issues and opportunities facing the industry.
Quell utilizes NeuroMetrix's patented neurostimulation technology to provide widespread relief from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell includes a smartphone app that tracks and personalizes their pain therapy. It is available for purchase at QuellRelief.com, selected retailers and healthcare professionals.
NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.